Biomerica (BMRA) Stock Statistics & Valuation Metrics

Biomerica has a market cap or net worth of $7.74M. The enterprise value is $5.82M.

Biomerica has 2,815,410 shares outstanding. The number of shares has decreased by -2.65% in one year.

Biomerica’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Biomerica is ―. Biomerica’s PEG ratio is ―.

In the last 12 months, Biomerica had revenue of 5.31M and earned -4.97M in profits. Earnings per share was -2.16.

In the last 12 months, operating cash flow was -3.84M and capital expenditures 0.00, giving a free cash flow of -3.84M billion.

Biomerica pays an annual dividend of ―, resulting in a dividend yield of ―

Biomerica upcoming earnings date is Oct 10, 2025, TBA (Confirmed).

Biomerica as a current ratio of ―, with Debt / Equity ratio of 9.81%

In the past 12 months, Biomerica has paid 1.00K in taxes.

Biomerica EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Biomerica has $2.40M in cash and marketable securities with $543.00K in debt, giving a net cash position of -$1.94M billion.

Gross margin is 13.47%, with operating margin of ―, and net profit margin of ―.

The average price target for Biomerica is $3.00, which is 11.43% higher than the current price. The consensus rating is Moderate Sell